{"transactions":[{"id":2199749,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-08-01T23:18:01.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 7/21/2022, and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2023, until fully vested."}],"balance_after":1493846,"derivative":{"exercise_price":0.33,"expiration_date":"2032-07-21","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001437749-22-018298","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774922018298/rdgdoc.xml","form_type":"4"}},{"id":2642973,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-07-06T20:33:08.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 7/1/2021, and the remaining 75% will vest over the next three (3) years, commencing on 7/1/2022, until fully vested."}],"balance_after":1025506,"derivative":{"exercise_price":0.79,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001437749-21-016459","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921016459/rdgdoc.xml","form_type":"4"}},{"id":2999027,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Warrant (right to buy)","published_at":"2020-10-28T20:41:59.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":3846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."}],"balance_after":705506,"derivative":{"exercise_price":0.57,"exercise_date":"2020-10-22","expiration_date":"2025-10-22","underlying":"Common Stock","underlying_shares":3846},"source":{"system":"sec-edgar","filing":"0001437749-20-021855","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920021855/rdgdoc.xml","form_type":"4"}},{"id":2999026,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2020-10-28T20:41:59.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":7692,"price":0.52,"value":3999.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased pursuant to public offering that closed on October 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchased pursuant to public offering that closed on October 22, 2020."}],"balance_after":27692,"source":{"system":"sec-edgar","filing":"0001437749-20-021855","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920021855/rdgdoc.xml","form_type":"4"}},{"id":3100370,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-06-25T20:42:44.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested."}],"balance_after":701660,"derivative":{"exercise_price":0.61,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-20-013874","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920013874/rdgdoc.xml","form_type":"4"}},{"id":3367384,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2019-11-19T22:01:23.000Z","date":"2019-11-15","kind":"purchase","acquired":true,"shares":10000,"price":0.39,"value":3900.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-19-023220","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774919023220/rdgdoc.xml","form_type":"4"}},{"id":3477698,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Stock Options (right to buy)","published_at":"2019-06-27T20:16:15.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested."}],"balance_after":551660,"derivative":{"exercise_price":0.43,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-19-012916","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774919012916/rdgdoc.xml","form_type":"4"}},{"id":3762531,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"COO, CSO"}}],"security":"Common Stock","published_at":"2018-11-16T23:37:37.000Z","date":"2018-11-16","kind":"purchase","acquired":true,"shares":10000,"price":0.4,"value":4000.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-18-021027","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918021027/rdgdoc.xml","form_type":"4"}},{"id":3889971,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"officer":true,"officer_title":"COO, CSO"}}],"security":"Stock Options (right to buy)","published_at":"2018-06-20T00:23:40.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/13/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/13/2019, until fully vested."}],"balance_after":401660,"derivative":{"exercise_price":0.46,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-18-012091","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918012091/rdgdoc.xml","form_type":"4"}},{"id":4270745,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CSO"}}],"security":"Stock Options (right to buy)","published_at":"2017-06-29T21:19:24.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.605,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001642247-17-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000164224717000011/primary_doc.xml","form_type":"4"}},{"id":4270744,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CSO"}}],"security":"Stock Options (right to buy)","published_at":"2017-06-29T21:19:24.000Z","date":"2017-06-15","kind":"disposition_to_issuer","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option."}],"balance_after":0,"derivative":{"exercise_price":0.93,"expiration_date":"2026-06-21","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001642247-17-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000164224717000011/primary_doc.xml","form_type":"4"}},{"id":4270743,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":125032,"kind":"person","name":"Cavanagh William","position":1,"cik":"0001503593","reported_name":"Cavanagh William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CSO"}}],"security":"Stock Options (right to buy)","published_at":"2017-06-29T21:19:24.000Z","date":"2017-06-15","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option."}],"balance_after":0,"derivative":{"exercise_price":1.47,"expiration_date":"2025-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001642247-17-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000164224717000011/primary_doc.xml","form_type":"4"}}]}